Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Helicos -- Ignore unavailable to you. Want to Upgrade?

To: TheSlowLane who wrote (10)	10/29/2007 5:30:57 PM
From: Steve Lokness	Read Replies (1) \| Respond to of 29

Theslowlane; The follow is from a link on google finance page for HLCS; Stanley Lapidus: "We believe we have the best platform and the best trajectory. I didn't start this company to do the Neanderthal [genome]... It's really about medicine. It's about reducing morbidity and reducing mortality, living longer and better lives." He adds: "It's inconceivable ten years from now that anything other than single- molecule technology will be used for nucleic acid measurements. Maybe it isn't Helicos, but I believe it will be." As excited as he is about the technology and the business opportunity, Lapidus relishes the bigger picture. "This is my shot - and Helicos' shot - at being more than a footnote in the history of science," he says. Recalling the importance and excitement of the era of microbe hunting, Lapidus sees the coming era of next-generation sequencing as "an age whose opportunity to change the quality of life of mankind for the better is just as profound as it was then." bio-itworld.com Interesting sector that is for sure! steve